Endosense Appoints Nicolas Marsault as New Chief Financial Officer

GENEVA--(BUSINESS WIRE)--Endosense, a pioneer and leader in contact-force sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has named Nicolas Marsault as its new chief financial officer. Marsault joins the company as it continues to expand the commercial presence of its TactiCath® contact-force sensing ablation catheter in Europe and prepares for the device’s anticipated launch in the United States. His appointment follows the closing of a USD 40.3 million/CHF 37.4 million series C financing round, announced by Endosense on November 27. “We welcome Nicolas to our team at a pivotal time of growth for the company,” said Jan Keltjens, Endosense president, chief executive officer and chairman of Endosense. “With his strong background in both finance and science, we expect him to play a critical role in the expansion of our business worldwide.”